APPLICATIONS PUBLISHED 2 JANUARY 2003 (pt A)

Published: 1-Jul-2003

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492

  • Use of CDP-choline for the treatment of alcohol withdrawal syndrome
    Ferrer Internacional 1267892*

  • Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
    Dynavax Technologies 1267893*

  • Bile acid containing prodrugs with advanced bioavailability
    University of Maryland, Baltimore 1267898*

  • Salmonella vaccine materials and methods
    Pharmacia & Upjohn 1267899*

  • Methods of treating glaucoma
    Pharmacia & Upjohn 1267903*

  • Polypeptide pulmonary surfactants
    Northwestern University; Chiron Corp 1267904*

  • Compsn for the treatment of heart failure
    Medinnova 1267905*

  • Lactams as inhibitors of A-beta protein production
    Bristol-Myers Squibb 1267906*

  • Vaccine for the treatment of atherosclerosis
    SmithKline Beecham 1267908*

  • Methods of blocking tissue restruction by autoreactive T cells
    The Ohio State University Research Foundation 1267909*

  • Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
    Stryker Corp 1267910*

  • Effects of glucagon-like peptide-1 (7-36) on antro-pyrolo-duodenal motility
    Goeke, Burkhard; Schirra, Joerg 1267912*

  • Methods for the administration of therapeutic agents on an antiangiogenic schedule
    EntreMed; The Children's Medical Centre Corp 1267913*

  • Use of lysosomal acid lipase for treating atherosclerosis and related diseases
    Children's Hospital Medical Centre 1267914*

  • Methods of treating diseases with activated protein C
    Eli Lilly 1267915*

  • Medicament containing a tissue inhibitor of metalloproteinases-2 (TIMP-2) as an osteo-anabolically active substance
    IPF Pharmaceuticals 1267916*

  • Angiogenic Onchocerca volvulus proteins and use thereof
    New York Blood Centre; Case Western Reserve University; The UAB Research Foundation 1267917*

  • Method of treatment using ligand-immunogen conjugates
    Purdue Research Foundation 1267918*

  • A method for generating immunogens that elicit neutralising antibodies against fusion-active regions of HIV envelope proteins
    Panacos Pharmaceuticals 1267919*

  • Cold-adapted equine influenza viruses
    University of Pittsburgh in the Commonwealth System of Higher Education 1267920*

  • Compsn and method for the prevention and/or the treatment of allergy
    K.U. Leuven Research & Development VZW 1267921*

  • Pneumococcus polysaccharide conjugats for use as vaccine against tetanus and diphtheria
    Aventis Pasteur 1267922*

  • Use of aliphatic quaternary ammonium as adjuvant in a pharmaceutical compsn administered by mucosal delivery
    Pierre Fabre Medicament 1267923*

  • Immunotherapeutic methods and compsns
    Lamellar Therapeutics 1267924*

  • Treatment of fungal infection with polyene or beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies
    Neutec Pharma 1267925*

  • Methods of inhibiting stenosis and restenosis with a mixture of antibodies anti CD10 and anti CCR2
    Millennium Pharmaceuticals 1267926*

  • You may also like